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Abstrak
Kasus kematian dalam HIV/AIDS masih menjadi tolak ukur keberhasilan pengobatan. Kajian 
tentang prediktor kematian pada Odha di populasi umum masih sangat terbatas. Metode 
yang di gunakan Longitudinal analitik dengan pendekatan retrospektif menggunakan 
data kohort pasien yang menerima ARV (antiretroviral) di RSUD Buleleng dalam periode 
waktu 2006-2015. Analisa menggunakan regresi logistic dengan SPSS versi 17. Hasil 
menunjukkan dari total 1204 bahwa insiden rate kematian total sebesar 3 per 100 person 
years. Kasus kematian 50% terjadi pada 0.14 tahun pengamatan. Laki-laki dan status 
fungsional kerja terbulti sebagai prediktor kematian pada odha. Laki-laki memiliki risiko 
kematian 2.12 kali lebih tinggi dibangingkan perempuan (aOR 2.12 (p 0.01 CI 1.28-3.51). 
Status fungsional baring  meningkatkan risiko kematian aOR 2.14 (CI 1.39-3.29 p 0.01). 
Kesimpulannya yaitu  laki-laki memiliki risiko kematian yang lebih besar dibandingkan 
perempuan. Sebaiknya evaluasi keberhasilan terapi ARV mempertimbangkan kajian 
dan perbedaan kebutuhan antara perempuan dan laki-laki. Status fungsional baring 
menunjukkan kondisi klinis yang buruk sehingga meningkatkan risiko kematian pada 
Odha. Evaluasi terhadap keteraturan pengobatan dan kejadian kematian berbasis gender 
sebaiknya dilakukan lebih intensif.
Kata kunci: sex, HIV/AIDS, status fungsional
Abstract
Cases of death in HIV / AIDS are still a benchmark for the success of treatment. Studies 
of predictors of death in people with HIV in the general population are still very limited. 
Longitudinal analytic with a retrospective approach using cohort data of patients receiving 
antiretroviral drugs at Buleleng General Hospital in the period 2006-2015. The analysis 
uses logistic regression with SPSS version 17. Results show a total of 1204 that the 
incidence of total mortality rate is 3 per 100 person-years. 50% of deaths occurred at 
0.14 years of observation. Men and the general functional status of employment were 
predictors of death in PLHAs. Men have a risk of death 2.12 times higher than that of 
women (aOR 2.12 (p 0.01 CI 1.28-3.51). The functional status of beds increases the risk of 
death aOR 2.14 (CI 1.39-3.29 p 0.01). Men have a risk of death evaluation of the success 
of antiretroviral therapy considers studies and differences in needs between women and 
men. The functional status of beds shows a poor clinical condition that increases the risk 
of death in people with HIV. Evaluation of regularity of treatment and the incidence of 
gender-based deaths should be done more intensively.
Keyword:  sex, human immunodefi ciency virus/ acquired immuno defi ciency syndrome,   
functional status
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INTRODUCTION
The HIV / AIDS epidemic is still a global 
issue that continues to receive special attention. 
Various programs have been developed 
to achieve the goal of reducing the risk of 
transmission. The four pillars of HIV / AIDS 
prevention in Indonesia all lead to the paradigm 
of zero new infection, zero AIDS-related death 
and zero discrimination including prevention, 
care, support and treatment, impact mitigation, 
and conducive environmental preparation(1,2). 
 The death of HIV / AIDS patients after 
receiving therapy in Bali is the seventh-highest 
percentage of deaths in Indonesia. This fi gure 
is still below the national death rate (18.04%), 
but it is still far from the target of zero AIDS-
related death.  Likewise, the cumulative loss to 
follow up (LTFU) incidence trend in Indonesia 
has increased, as of June 2013 by 15.74% to 
17.95% as of June 2014. Bali Province ranks 
fi fth in Indonesia in terms of the number of HIV 
/ AIDS cases. In the second quarter of 2014 in 
Bali Province, there were 5802 PLHIV who had 
received ARV therapy with 3598 still on ARV 
therapy, 1063 LTFU, 664 died, 459 referred 
out and 18 stopped ARV therapy (1).  Buleleng 
Regency is the second-largest area in Bali 
Province with the second-highest number of HIV 
cases with 593 cases (13.92%)(1).
The success of ARV therapy requires 
adherence to therapy for HIV / AIDS patients so 
patient compliance must always be monitored 
and evaluated regularly at each visit. Failure of 
antiretroviral therapy is often caused by non-
compliance with patients taking ARVs (2-5). 
Gender is a variable that greatly determines the 
pattern of adherence in antiretroviral therapy. 
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The risk of death in men tends to be higher (RR 
1.19, aSHR 1.7) compared to women (6,7). The 
beginning of treatment is also a consideration 
of the success of the therapy given. Clinical 
conditions often related to the incidence of death 
in PLHAs are bodyweight, CD4 cell count, clinical 
stage and functional status. Studies on predictors 
of PLHIV death by ARV therapy in Bali Province, 
in particular, are still limited. This study aims to 
analyze the predictors of death in people with 
HIV in ARV therapy in Buleleng District Hospital
MATERIALS AND METHODS 
This study is a longitudinal analytic study 
with a retrospective approach using cohort 
data of patients receiving antiretroviral drugs in 
Buleleng Regional Hospital in the 2006-2015 time 
period and taking them cross-sectional. Analysis 
using logistic regression with SPSS version 17. 
The study was conducted at the Edelweis VCT 
Polyclinic of Buleleng District Hospital during the 
study period, November-December 2018. Data 
were collected using data collection forms that 
are still in the form of hard copies made into soft 
copies (in the form of Microsoft Excel) for easy 
analysis. Data collected in the form of secondary 
data from medical records and patient cohort 
registers. The number of samples in this study 
was 1204 people with a period of observation 
from 2005-2014. The research instrument 
used was the medical record observation 
sheet. Data were analyzed using multivariate 
logistic regression analysis using the backward 
method, the existence of a confounding variable 
determined by a signifi cance of 5% and a change 
in survival/hazard rate of 10% or more in the main 
variable with the SPSS 17 software program.
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The sample research selection procedure 
is illustrated in Figure 1.
Observations made during VCT practice 
by looking at cohort register studies that the 
incidence of death in people with HIV is still high. 
Besides, the level of patient adherence to therapy 
is still low as evidenced by the high percentage 
of LTFU and mortality in people with HIV in 
Buleleng Hospital. It is hoped that the results of 
this study will provide an overview of the clinical 
and demographic conditions of PLHAs who have 
received ARV therapy for the past 10 years.
RESULTS AND DISCUSSION
The results of the study of 1204 PLHA 
patients data that met the inclusion criteria that 
the percentage of death cases was 9.30%. 
The proportion of deaths in men is 79.46% and 
women are 20.54%. The mortality rate is 3 per 
100 person-years with a median time of death 
Patient RSU Buleleng 1204 
(92%)
- Still ARV therapy 842 (69.9%)
- Died 112 (9.3%)
- LTFU 180 (14.9%)
- LTFU-Died 37 (3.1%)
- LTFU- Life 6 (0.5%)
- Stop Treatment 5 (0.4%)
- Refer out 22 (1.8%) 
Inclusion criteria
1204 people (92%)
HIV / AIDS Patients ARV Therapy 
RSUD Buleleng (2006-2015)
1306 people
Exclusion criteria:
-  Age <15 years 43 people (3.3%)
- One visit 43 people (3.3%)
- Pregnant Women 16 (1.2%)
Figure 1. Sample Research Selection Procedure
Graph 1. Survival of People with HIV Based on Functional Status
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Graph 2. Survival of PLHIV Based on Gender
at 0.14 years (1.7 months) of observation. This 
condition shows that of the 112 deaths in PLHAs 
who received ARV therapy 50% of deaths 
occurred at 5.25 years after therapy. Based on 
functional and gender status conditions, survival 
rates for PLHAs are illustrated in the graph below:
Based on table 1 shows that the percentage 
of deaths of HIV-positive people mostly occurred 
in men (79.46%), access to health facilities more 
than 5 kilometers (86.61%), functional status 
(54.29%), clinical stages 3 and 4 (90.91%), 
body weight less than 50 kilograms (73.91%), 
CD4 levels less than 200 cells / mm3 (94.59%), 
zidovudine type therapy (75.70%) and nevirapine 
type regimens (81.83%). After the proportion 
test was performed, there was a statistically 
signifi cant difference in the proportion of cases 
of death of HIV-positive people based on sex 
(p 0.01), functional status (0.01), clinical-stage 
(0.01), weight (0.04), CD4 level (0.01) and NRTI 
regimen (p 0.01). In multivariate analysis, not all 
of the variables to enter because two-variable 
have missing data more than 50 % were weight 
and CD4.
Multivariate analysis shows that two 
variables are predictors of death in people with 
HIV, namely sex and functional status. HIV-
positive men with gender are 2.12 times more 
Tabel 1. Condition of Death in People with HIV Based 
on Clinical and Demographic Characteristics
Characteristics Death PLWH  n % p
1 2 3 4
Sex 0.01*
 Female 23 20.54
 Male 89 79.46
Distance from Health Facilities 0.54
≤ 5 km 15 13.39
>  5 km 97 86.61
Functional Status 0.01*
Baring 57 54.29
Ambulatory 41 39.05
Kerja 7 6.67
Stadium Klinis 0.01*
Stadium 1 dan 2 9 9.09
Stadium 3 dan 4 90 90.91
Weight 0.04*
>50 kg 6 26.09
≤ 50 kg 17 73.91
CD4 0.02*
>200cell/mm3 2 5.41
≤ 200cell/mm3 35 94.59
NRTI 0.01*
Tenofovir 9 8.41
Stavudine 17 15.89
Zidovudine 81 75.70
NNRTI 0.16
Evapirine 20 18.69
Nevirapine 87 81.83
at risk of dying than women, while functional 
status conditions, which are lying, also have a 
risk of 2.14 times death compared to working and 
ambulatory conditions.
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Table 2. Multivariate Predictors of Death of People 
with HIV in ARV Therapy in Buleleng Hospital.
Characteristics
Odds Ratio (95 
% CI) p
1 2 3
Sex 
 Female 1.00 (ref)
Male 2.12 (1.28-3.50) 0.01*
Functional Status
Baring 1.00 (ref)
Ambulatory 0.33 (0.15-0.75) 0.03*
Kerja 2.14 (1.39-3.29) 0.01*
Distance from Health Facilities 
≤ 5 km 1.00 (ref)
>  5 km 2.23 (0.28-17.49) 0.44
Stadium Klinis 
Stadium 1 dan 2 1.00 (ref)
Stadium 3 dan 4 2.07 (0.54-7.84) 0.28
NRTI
Tenofovir 1.00 (ref)
Stavudine 2.23 (0.28-17.49) 0.44
Zidovudine 2.20 (0.25-15.50) 0.54
NNRTI
Evapirine 1.00 (ref)
Nevirapine 4.56 (0.28-15.49) 0.78
* p-value < 0,05 untuk multivariate
The incidence in this study is lower 
when compared to TAHOD TREAT (Asia HIV 
Observational Database ) data which includes 18 
sites in the Asia Pacifi c region, which is 21.4 per 
100 PY, but is higher when compared to countries 
in Southeast Asia such as India (7.1 per 100 PY) 
and Vietnam ( 8.9 per 100 PY) (7–9). Likewise, 
if compared with developed countries, it tends to 
have a lower incidence such as France (4.3 per 
100 person-years) and Europe (3,272 per 100 
person-years)(6).
Deaths to PLHAs are an important measure 
of the success of ARV therapy. The clinical 
condition is an important study before starting 
therapy. People with HIV who start therapy in 
poor clinical conditions have a higher risk of 
death (7,8). 
Men with HIV have a 2.1 times risk of 
dying compared to women. This is very possible 
because the behavior and compliance of men 
are lower than women. Men are more at risk of 
death because they tend to come to the service 
when sick and are less willing to provide detailed 
information. 6 Men have variations in mobility and 
a high risk of drug abuse that can interfere with 
adherence to antiretroviral therapy so that they 
are more likely to experience death.7 Most men 
with drug addiction experience higher toxicity 
due to interactions with ARV drugs that lead to 
discontinuation of therapy. 8 The conditions are 
different for women who are more likely to come 
to health care facilities than men for reproductive 
services and child health services.9 Women 
may seek immediate care because they are the 
primary caregivers in the family and feel they 
have a greater responsibility to stay healthy.10 
Men are more likely to experience death if they 
have advanced disease, this shows that death in 
men is likely to occur due to a disease that gets 
worse or death. 9
Functional status in the lying category is a 
predictor of death in people with HIV with aOR 
2.14 (CI 1.39-3.29 p 0.01). The condition of 
lying in PLHAs receiving ARV therapy is closely 
related to poor clinical status. Functional status 
assessment is based on observations and 
interviews conducted following its categorization 
criteria. Functional status in PLHAs can be 
divided into three namely work status, ambulatory 
and lying. Working status is categorized if PLHAs 
are still able to work normally, patients who are 
unable to work normally and <50% lying down 
are categorized as having an ambulatory status, 
while patients who are continuously (or> 50%) 
lying in bed are categorized as lying (11). The 
main purpose of ART is to provide opportunities 
for people to be productive in their work and daily 
life. Therefore, productivity measures that are 
functional status can be used as an indicator of 
the success of ART programs (12).  Patients with 
poor clinical conditions are easily seen from the 
functional status indicated. Most of those who 
come with bedridden conditions have worse 
clinical conditions so that the chance of death 
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is also greater (11-14). Functional status is 
ambulatory also increases the risk of LTFU with 
an adjusted sHR of 1.25 (95% CI: 1.01 to 1.54) 
(13). Other studies have shown that ambulatory 
functional status is a protective factor against 
mortality in people with HIV (aHR 0.4 95% CI 
0.3-0.6 p = 0.001) (13). 
The results of this study indicate that 
gender and functional status can be important 
studies to consider before starting ARV therapy. 
HIV pre and posttest counseling should be done 
more intensively to avoid non-compliance with 
therapies that can result in death.
CONCLUSION AND RECOMMENDATION
The incidence of death in PLHAs on ARV 
therapy in the last 10 years reached 3 per 100 
person-years with a median time of death at 0.14 
years (1.7 months) observation. Sex classifi cation 
is that men have a risk of death 2 times greater 
than women. Lying functional status increases 
the risk of death by 2.1 times. It is recommended 
that the evaluation of the success of ARV therapy 
considers the study and differences in needs 
between women and men without ignoring their 
functional status. Evaluation of the regularity of 
treatment and gender-based death events should 
be done more intensively.
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